Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1Gastrointestinal 1Endocrine 1Breast 1

Conditions

Adrenocortical Carcinoma 6Thyroid Carcinoma, Anaplastic 4Neoplasm Metastasis 4Sarcoma 3Pheochromocytoma 3Thyroid Neoplasms 2Sarcoma, Synovial 2Sarcoma, Endometrial Stromal 2Ovarian Neoplasms 2Neurofibrosarcoma 2Neuroendocrine Tumors 2Neoplasms 2Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Kidney Neoplasms 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Head and Neck Neoplasms 2Fibrosarcoma 2Endometrial Neoplasms 2Thyroid Cancer, Papillary 1Somatostatinoma 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Mesothelioma, Malignant 1

Interventions

Everolimus 3Sunitinib 2Octreotide 2repotrectinib 1pralsetinib 1pasireotide 1lutetium Lu 177 dotatate 1epothilone B 1cixutumumab 1belinostat 1azaspirane 1avelumab 1Radiotherapy 1Lutetium-177 1Etoposide 1Doxorubicin 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Doxorubicin × Endocrine × Clear all
NCT00804830 2018-08-28

Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer

Region Skane

Phase 2 Terminated
15 enrolled
EndocrineHead & Neck

Carcinoma, Neoplasm Metastasis, Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡